Renewed Hope for Stage Four Breast Cancer PatientsThe Only F
Saturday, February 7th, 2009
Renewed Hope for Stage Four Breast Cancer PatientsThe Only FDA Cleared Serum, HER-2/neu Blood Test, May Help Treat Metastatic Breast Cancer More Effectively - Even though most women know the importance of early detection and yearly screenings in the fight against breast cancer, each year thousands receive a devastating diagnosis of stage four breast cancer. In fact, each year more than one-in-four breast cancer patients are diagnosed with a highly aggressive breast cancer known as HER-2 neu positive, which until recently was considered seldom treatable.
Now a new therapy monitoring test, Siemens HER-2/neu blood test, is giving renewed hope to metastatic breast cancer patients. The test is the only FDA cleared serum HER-2/neu blood test, which can indicate whether metastatic breast cancer is progressing or responding to treatment. The test helps doctors to monitor and treat their patients with more targeted therapies.
Periodic HER-2/neu blood tests help monitor the effectiveness of these therapies and plan future ones. By combining advanced drug therapies, routine mammograms, advanced breast ultrasounds and MRIs, doctors have been able to fight many metastatic cancers more effectively.
Duration : 0:1:52
http://www.neomatrix.com - The HALO Test is a new screening process to ess a woman’s risk for developing breast cancer. It works similarly to a pap smear by detecting abnormal cells long before cancer might develop. While a mammogram is recommended for women 40 and older, HALO is for women 25 and older.
Renewed Hope for Stage Four Breast Cancer PatientsThe Only FDA Cleared Serum, HER-2/neu Blood Test, May Help Treat Metastatic Breast Cancer More Effectively - Even though most women know the importance of early detection and yearly screenings in the fight against breast cancer, each year thousands receive a devastating diagnosis of stage four breast cancer. In fact, each year more than one-in-four breast cancer patients are diagnosed with a highly aggressive breast cancer known as HER-2 neu positive, which until recently was considered seldom treatable.
Renewed Hope for Stage Four Breast Cancer PatientsThe Only FDA Cleared Serum, HER-2/neu Blood Test, May Help Treat Metastatic Breast Cancer More Effectively - Even though most women know the importance of early detection and yearly screenings in the fight against breast cancer, each year thousands receive a devastating diagnosis of stage four breast cancer. In fact, each year more than one-in-four breast cancer patients are diagnosed with a highly aggressive breast cancer known as HER-2 neu positive, which until recently was considered seldom treatable.
http://www.neomatrix.com - New Technology can warn of breast cancer risk years before cancer develops.
http://www.neomatrix.com - The FDA-approved HALO Breast Pap Test is a simple, five-minute test that identifies warning signs of breast cancer risk long before cancer might develop and years before traditional mammograms and manual exams uncover an actual lump. The HALO test provides early warning signs of breast cancer risk, particularly among younger women who have no other known risk factors. This early breast cancer warning system gives women and their doctors precious extra time to implement a more vigilant, personalized breast health treatment plan.
http://www.neomatrix.com - The HALO Test is a noninvasive way to check for early signs of breast cancer risk.
Even though most women know the importance of early detection and yearly screenings in the fight against breast cancer, each year thousands receive a devastating diagnosis of stage four breast cancer. In fact, each year more than one-in-four breast cancer patients are diagnosed with a highly aggressive breast cancer known as HER-2 neu positive, which until recently was considered seldom treatable.
http://www.neomatrix.com Mammography is recommended by age 40, but Halo offers an alternative to younger women for detecting early signs of breast cancer.